Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...

The company has crossed $100 million in annual recurring revenue as enterprises clean up their data to train AI models.

Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2025. At this time, all participants have been placed in a listen-only mode and the call will ...

Glean, a maker of search chatbots and agents for businesses, has more than doubled its customer base in the last year alone, ...

CFO Simona King reported record net revenue of $88.2 million and a 316% increase in adjusted EBITDA to $23.1 million, marking the ninth consecutive quarter of positive adjusted EBITDA. The company ...

Aurora Cannabis Inc., a leading Canadian-based global medical cannabis company, has reported its financial and operational ...

NOVATO, Calif. - Ultragenyx Pharmaceutical Inc. (NASDAQ: NASDAQ:RARE), a $4.08 billion market cap biotechnology company with 27% revenue growth in the past year, today unveiled new data indicating ...

Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year to $81.5 billion. On the basis of U.S. generally ...

Q4 2024 Management View CEO Kevin Hykes highlighted strong revenue growth of $15.3 million for Q4 2024, representing a 36% increase year-over-year. U.S. Heart Failure revenues grew by 41%, supported ...